Healthcare >> CEO Interviews >> May 3, 2004

Andrew Heath – Protherics Plc (pti.l)

DR. ANDREW J. HEATH is the Chief Executive of Protherics Plc. He has both clinical and commercial experience in the Pharmaceutical industry. Until 1996, he was responsible for more than 500 sales and marketing professionals at Astra USA. He served as Chief Executive Officer at AeroGen, Inc., a privately held drug delivery company, from 1996 until 1998, joining Therapeutic Antibodies (now Protherics Plc) as Chief Executive Officer in March 1998. Dr Heath holds an MD and PhD from Sweden's Gothenberg University. Profile
TWST: Could you give us a capsule summary of what Protherics?

Dr. Heath: Protherics is an international biopharmaceutical business.

Our focus is late-stage development, manufacturing of our